{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-026533","form_type":"8-K","ticker":"AKTX","cik":"0001541157","company_name":"Akari Therapeutics Plc","filed_at":"2025-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.692582+00:00","generated_at":"2026-05-16T13:57:51.980037+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Akari Therapeutics furnishes investor presentation for conferences","bullets":["Investor presentation furnished as Exhibit 99.1 on December 8, 2025.","Presentation intended for use at conferences and meetings by company officers.","No specific financial or pipeline details disclosed in the filing body.","Filing signed by President and CEO Abizer Gaslightwala."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-026533","json":"https://secwatch.observer/filing/0001493152-25-026533.json","markdown":"https://secwatch.observer/filing/0001493152-25-026533.md","text":"https://secwatch.observer/filing/0001493152-25-026533.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1541157/000149315225026533/0001493152-25-026533-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1541157/000149315225026533/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:57:51.980037+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}